← Browse by Condition
Medical Condition
advanced breast cancer
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 1, Phase 2, Phase 3, Phase 1
NCT06298084 Phase 1, Phase 2
Recruiting
Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd
Enrollment
152 pts
Location
France
Sponsor
Gustave Roussy, Cancer Campus,...
NCT06548919
Recruiting
Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer
Enrollment
450 pts
Location
China
Sponsor
SciClone Pharmaceuticals
NCT06044623 Phase 3
Recruiting
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Enrollment
495 pts
Location
Finland, Greece, Ita...
Sponsor
Region Örebro County
NCT06997029 Phase 1
Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Enrollment
234 pts
Location
United States, Denma...
Sponsor
Bristol-Myers Squibb
NCT06382948 Phase 3
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Enrollment
240 pts
Location
Austria, Czechia, Fr...
Sponsor
MedSIR
NCT06895291
Recruiting
Whole Body MRI in Oncology
Enrollment
1,000 pts
Location
Italy
Sponsor
Istituto Romagnolo per lo Stud...
NCT06123988
Recruiting
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
Enrollment
260 pts
Location
United States
Sponsor
University of Miami
NCT07405931
Recruiting
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Enrollment
414 pts
Location
South Korea
Sponsor
Ulsan University Hospital
NCT06500494
Recruiting
To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment
Enrollment
368 pts
Location
Algeria, China, Ital...
Sponsor
Pierre Fabre Medicament
NCT06217185 Phase 4
Recruiting
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
Enrollment
100 pts
Location
China
Sponsor
Hebei Medical University Fourt...
NCT05452213 Phase 4
Recruiting
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
Enrollment
1,000 pts
Location
Germany
Sponsor
Institut fuer Frauengesundheit